Company Filing History:
Years Active: 2020
Title: Matthew Bird - Innovator in Peptide Conjugation Technology
Introduction
Matthew Bird is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biochemistry, particularly in the area of peptide and protein conjugation. His innovative work has led to the development of novel reagents that enhance the efficiency of biochemical reactions.
Latest Patents
Matthew Bird holds a patent for a process that involves the conjugation of a peptide or protein with a reagent comprising a leaving group that includes a portion of PEG. This invention relates to novel conjugating reagents capable of reacting with at least one nucleophile present in a peptide or protein. The reagents contain at least one leaving group that is lost upon reaction with the nucleophile, specifically including a portion —(CHCHO)—, where n is a number of six or more. This patent represents a significant advancement in the preparation of conjugates containing peptides or proteins.
Career Highlights
Matthew Bird is currently associated with Polytherics Limited, where he applies his expertise in peptide chemistry. His work at the company has been instrumental in advancing the field of bioconjugation, leading to improved methodologies and applications in drug development and therapeutic interventions.
Collaborations
Matthew has collaborated with notable colleagues such as Antony Robert Godwin and George Badescu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of biochemistry.
Conclusion
Matthew Bird's contributions to peptide conjugation technology exemplify the impact of innovative thinking in the scientific community. His patent and work at Polytherics Limited highlight the importance of advancements in biochemistry for future therapeutic applications.